10/16/2026
Brain photobiomodulation is stepping into the mainstream spotlight 💡
Vielight founder and CEO Dr. Lew Lim recently joined the set at CBS News (8 News Now) in Las Vegas to discuss groundbreaking neuroimaging data and traumatic brain injury (TBI) research by the University of Utah, powered by the Vielight Neuro.
While awareness of light therapy is accelerating, the Vielight advantage comes down to engineering, precision, and IP 🧠
Vielight and Dr. Lim hold the industry’s most comprehensive patent portfolio in brain photobiomodulation, anchored by two critical pillars:
- Intranasal-transcranial PBM: Combining transcranial and intranasal photobiomodulation to deliver near-infrared (NIR) light to the top and bottom regions of the brain - creating an insurmountable advantage over transcranial-only devices.
- Intelligent Personalization: Proprietary algorithms and patent-protected technology for AI-based adaptive, and personalized photobiomodulation dosing.
Validating advanced neurotechnology requires both rigorous clinical data and proprietary innovation. Watch this space as we and our research partners continue pushing the boundaries of research and innovation.
Read the research here: https://www.vielight.com/research
Read the patentes here: https://www.vielight.com/vielight-patents/